Hong Kong Biopharmaceutical Stocks Rise Amid Market Volatility
Hong Kong's biopharmaceutical sector experienced notable gains as several stocks surged amid market fluctuations. According to Jin10, XuanZhu Biopharma-B (02575.HK) saw an increase of over 12%, while Ascletis Pharma (01672.HK) rose by more than 7%. Additionally, Lepu Biopharma (02157.HK) and XtalPi Holdings (02228.HK) both climbed over 6%, and Akeso Biopharma (09926.HK) increased by 5.5%. These movements reflect a positive trend in the biopharmaceutical industry within Hong Kong's stock market.
Source: CoinLive The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments